Non-Gaussian heart rate as an independent predictor of mortality in patients with chronic heart failure

Heart Rhythm

Volumn 5, Issue 2, 2008, Pages 261-268

  Kiyono, Ken ^a   Hayano, Junichiro ^b   Watanabe, Eiichi ^c   Struzik, Zbigniew R ^d   Yamamoto, Yoshiharu ^d  

^a NIHON UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Heart failure; Heart rate; Mortality; Probability density function; Risk factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART RATE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT INFORMATION; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SURVIVAL;

AGED; CHRONIC DISEASE; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NORMAL DISTRIBUTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 38649134175     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.10.030     Document Type: Article

References (32)

1. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
2. Pitt B., Poole-Wilson P.A., Segal R., et al., ELITE II investigators. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-The Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
3. Cohn J.N., Tognoni G., and The Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 (2001) 1667-1675
4. Bardy G.H., Lee K.L., Mark D.B., et al., The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
5. Cleland J.G., Daubert J.C., Erdmann E., et al., The Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
6. Peng C.K., Mietus J., Hausdorff J.M., et al. Long-range anticorrelations and non-Gaussian behavior of the heartbeat. Phys Rev Lett 70 (1993) 1343-1346
7. Yamamoto Y., and Hughson R.L. On the fractal nature of heart rate variability in humans: effects of data length and β-adrenergic blockade. Am J Physiol 266 (1994) R40-R49
8. Ivanov P.C., Amaral L.A.N., Goldberger A.L., et al. Multifractality in human heart rate dynamics. Nature 399 (1999) 461-465
9. Amaral L.A.N., Ivanov P.C., Aoyagi N., et al. Behavioral-independent features of complex heartbeat dynamics. Phys Rev Lett 86 (2001) 6026-6029
10. Kiyono K., Struzik Z.R., Aoyagi N., et al. Critical scale-invariance in healthy human heart rate. Phys Rev Lett 93 (2004) 178103
11. Kiyono K., Struzik Z.R., Aoyagi N., et al. Phase transition in healthy human heart rate. Phys Rev Lett 95 (2005) 058101
12. Kleiger R.E., Miller J.P., Bigger Jr. J.T., et al., The Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
13. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., et al., ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
14. Bigger Jr. J.T., Steinman R.C., Rolnitzky L.M., et al. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 93 (1996) 2142-2151
15. Huikuri H.V., Mäkikallio T.H., Peng C.K., et al. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 101 (2000) 47-53
16. Ponikowski P., Anker S.D., Chua T.P., et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79 (1997) 1645-1650
17. Ho K.K.L., Moody G.B., Peng C.K., et al. Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 96 (1997) 842-848
18. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 98 (1998) 1510-1516
19. Mäkikallio T.H., Huikuri H.V., Hintze U., et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 87 (2001) 178-182
20. Brouwer J., van Veldhuisen D.J., Veld A.J.M., et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol 28 (1996) 1183-1189
21. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
22. Gottlieb S.S., Kukin M.C., Ahern D., et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13 (1989) 1534-1539
23. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
24. Kiyono K., Struzik Z.R., Aoyagi N., et al. Multiscale probability density function analysis: non-Gaussian and scale-invariant fluctuations of healthy human heart rate. IEEE Trans Biomed Eng 53 (2006) 95-102
25. Kiyono K., Struzik Z.R., and Yamamoto Y. Estimator of a non-Gaussian parameter in multiplicative log-normal models. Phys Rev E 76 (2007) 041113
26. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93 (1996) 1043-1065
27. Peng C.K., Havlin S., Stanley H.E., et al. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 5 (1995) 82-87
28. Castaing B., Gagne Y., and Hopfinger E.J. Velocity probability density-functions of high Reynolds-number turbulence. Physica D 46 (1990) 177-200
29. Schmidt G., Malik M., Barthel P., et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353 (1999) 1390-1396
30. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77 (1988) 721-730
31. Ghashghaie S., Breymann W., Peinke J., et al. Turbulent cascades in foreign exchange markets. Nature 381 (1996) 767-770
32. Muzy J.F., Delour J., and Bacry E. Modelling fluctuations of financial time series: from cascade process to stochastic volatility model. Eur Phys J B 17 (2000) 537-548